An amyloid β42-dependent deficit in anandamide mobilization is associated with cognitive dysfunction in Alzheimer's disease
Keywords: مغز انسان; Endocannabinoid; Anandamide; Amyloid β42; Cognitive dysfunction; Alzheimer's disease; Human brain; Lipidomics;